203 related articles for article (PubMed ID: 21089753)
21. Proton beam radiotherapy for uveal melanoma: results of Curie Institut-Orsay proton therapy center (ICPO).
Dendale R; Lumbroso-Le Rouic L; Noel G; Feuvret L; Levy C; Delacroix S; Meyer A; Nauraye C; Mazal A; Mammar H; Garcia P; D'Hermies F; Frau E; Plancher C; Asselain B; Schlienger P; Mazeron JJ; Desjardins L
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):780-7. PubMed ID: 16647221
[TBL] [Abstract][Full Text] [Related]
22. Transpupillary thermotherapy for choroidal melanoma: tumor control and visual results in 100 consecutive cases.
Shields CL; Shields JA; Cater J; Lois N; Edelstein C; Gündüz K; Mercado G
Ophthalmology; 1998 Apr; 105(4):581-90. PubMed ID: 9544628
[TBL] [Abstract][Full Text] [Related]
23. Temporal Evolution and Dose-Volume Histogram Predictors of Visual Acuity After Proton Beam Radiation Therapy of Uveal Melanoma.
Polishchuk AL; Mishra KK; Weinberg V; Daftari IK; Nguyen JM; Cole TB; Quivey JM; Phillips TL; Char DH
Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):91-97. PubMed ID: 27838186
[TBL] [Abstract][Full Text] [Related]
24. Histopathology of eyes enucleated after endoresection of choroidal melanoma.
Hadden PW; Hiscott PS; Damato BE
Ophthalmology; 2004 Jan; 111(1):154-60. PubMed ID: 14711728
[TBL] [Abstract][Full Text] [Related]
25. Tumor-related lipid exudation after plaque radiotherapy of choroidal melanoma: the role of Bruch's membrane rupture.
Mashayekhi A; Tuncer S; Shields CL; Shields JA
Ophthalmology; 2010 May; 117(5):1013-23. PubMed ID: 20097428
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: a detailed analysis of tumor and dose-volume parameters.
Mishra KK; Daftari IK; Weinberg V; Cole T; Quivey JM; Castro JR; Phillips TL; Char DH
Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):330-6. PubMed ID: 23886415
[TBL] [Abstract][Full Text] [Related]
27. Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: A comparative study.
Weber DC; Bogner J; Verwey J; Georg D; Dieckmann K; Escudé L; Caro M; Pötter R; Goitein G; Lomax AJ; Miralbell R
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):373-84. PubMed ID: 16168832
[TBL] [Abstract][Full Text] [Related]
28. [Treatment of exterior extension of choroid melanomas by accelerated proton beams].
Bercher L; Zografos L; Egger E; Chamot L; Uffer S; Gailloud C; Ducrey N
Klin Monbl Augenheilkd; 1992 May; 200(5):440-3. PubMed ID: 1319525
[TBL] [Abstract][Full Text] [Related]
29. A case of quiescent choroidal melanoma: early echographic signs of reactivation.
Mancini A; Colangelo L; Lapi G; Lobefalo L; Ciancaglini M; Mastropasqua L; Gallenga PE
Ophthalmologica; 1998; 212 Suppl 1():57-60. PubMed ID: 9730753
[TBL] [Abstract][Full Text] [Related]
30. Palladium-103 plaque radiation therapy for American Joint Committee on cancer T3- and T4-staged choroidal melanomas.
Semenova E; Finger PT
JAMA Ophthalmol; 2014 Feb; 132(2):205-13. PubMed ID: 24287555
[TBL] [Abstract][Full Text] [Related]
31. Comparison of clinical outcomes for patients with large choroidal melanoma after primary treatment with enucleation or proton beam radiotherapy.
Mosci C; Lanza FB; Barla A; Mosci S; Hérault J; Anselmi L; Truini M
Ophthalmologica; 2012; 227(4):190-6. PubMed ID: 22269846
[TBL] [Abstract][Full Text] [Related]
32. Proton beam therapy for the treatment of uveal melanoma in Scotland.
Macdonald EC; Cauchi P; Kemp EG
Br J Ophthalmol; 2011 Dec; 95(12):1691-5. PubMed ID: 21216794
[TBL] [Abstract][Full Text] [Related]
33. Radiation maculopathy after proton beam irradiation for choroidal melanoma.
Guyer DR; Mukai S; Egan KM; Seddon JM; Walsh SM; Gragoudas ES
Ophthalmology; 1992 Aug; 99(8):1278-85. PubMed ID: 1325044
[TBL] [Abstract][Full Text] [Related]
34. A five-year study of slotted eye plaque radiation therapy for choroidal melanoma: near, touching, or surrounding the optic nerve.
Finger PT; Chin KJ; Tena LB
Ophthalmology; 2012 Feb; 119(2):415-22. PubMed ID: 22133796
[TBL] [Abstract][Full Text] [Related]
35. Ultrasonographic follow-up of primary choroidal malignant melanoma after proton beam irradiation therapy.
Romani A; Baldeschi L; Genovesi-Ebert F; Gremigni E; Ragone MC; Rizzo S; Nardi M
Ophthalmologica; 1998; 212 Suppl 1():50-2. PubMed ID: 9730751
[TBL] [Abstract][Full Text] [Related]
36. Carbon-ion radiotherapy for locally advanced or unfavorably located choroidal melanoma: a Phase I/II dose-escalation study.
Tsuji H; Ishikawa H; Yanagi T; Hirasawa N; Kamada T; Mizoe JE; Kanai T; Tsujii H; Ohnishi Y;
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):857-62. PubMed ID: 17161555
[TBL] [Abstract][Full Text] [Related]
37. Quantification of radiation retinopathy after beam proton irradiation in centrally located choroidal melanoma.
Busch C; Löwen J; Pilger D; Seibel I; Heufelder J; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1599-1604. PubMed ID: 29948179
[TBL] [Abstract][Full Text] [Related]
38. Transpalpebral proton beam radiotherapy of choroidal melanoma.
Konstantinidis L; Roberts D; Errington RD; Kacperek A; Heimann H; Damato B
Br J Ophthalmol; 2015 Feb; 99(2):232-5. PubMed ID: 25138766
[TBL] [Abstract][Full Text] [Related]
39. Long-term results of carbon ion radiation therapy for locally advanced or unfavorably located choroidal melanoma: usefulness of CT-based 2-port orthogonal therapy for reducing the incidence of neovascular glaucoma.
Toyama S; Tsuji H; Mizoguchi N; Nomiya T; Kamada T; Tokumaru S; Mizota A; Ohnishi Y; Tsujii H;
Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):270-6. PubMed ID: 23414768
[TBL] [Abstract][Full Text] [Related]
40. Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma.
Egger E; Schalenbourg A; Zografos L; Bercher L; Boehringer T; Chamot L; Goitein G
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):138-47. PubMed ID: 11516863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
